Enjoy the event with subtitles available in Spanish and English. *Subtitles are generated using artificial intelligence and may contain inaccuracies.
close
This content is not available in your location
This event is scheduled for
Only logged in users can watch the content
To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
Rethinking the Optimal Path for Rectal Cancer: Upfront Surgery and Neoadjuvant Therapy
JAPAN Precise Surgery - JSES
Share
share
Feb, 2026
Chat
keyboard_arrow_down
Description
keyboard_arrow_down
In recent years, the debate between upfront surgery and neoadjuvant therapy has become a cornerstone in the management of rectal cancer. Choosing the optimal path requires a deep understanding of varying international guidelines and the precision offered by modern surgical techniques.
Thanks to the integration of laparoscopic and robotic-assisted systems, surgeons can now achieve higher levels of precision in Local Axial Resection (LAR), adhering to rigorous clinical standards to improve patient quality of life.
Welcome and Introduction - by Dr. Soichiro Ishihara (Japan)
Advanced Lower Rectal Cancer: Clinical Guidelines and Surgical Excellence in Robotic LAR - Dr. Yoshiro Itatani (Japan)
The UK/European Perspective: Guidelines, Strategies, and the Upfront Surgery Debate - Dr. Jim S. Khan (UK)
Precision in Practice: Laparoscopic LAR Following Japanese Guidelines - Dr. Soichiro Ishihara (Japan)
Panel Discussion & Closing Remarks - Moderated by Dr. Soichiro Ishihara (Japan)
.webp)
